Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAD-M Regimen for Untreated Extranodal NK/T Cell Lymphoma
NCT01991158Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Nov 2013
- Primary completion
- Dec 2016
- Modality
- Therapeutic Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate, gemcitabine, pegaspargase, dexamethasone in Extranodal NK/T-cell lymphoma (ENKTL), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
methotrexategemcitabinepegaspargasedexamethasone
03
Conditions
Extranodal NK/T-cell lymphoma (ENKTL)
Beyond the preview
Go deeper on NCT01991158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01991158.